co.don AG Share Price Börse Stuttgart

Equities

CNW

DE000A3E5C08

Pharmaceuticals

Market Closed - Börse Stuttgart 01:15:07 13/06/2024 am IST 5-day change 1st Jan Change
0.0105 EUR -30.00% Intraday chart for co.don AG -27.59% -4.55%
Current month-27.59%
1 month-43.24%

Financials

Sales 2020 6.23M 6.73M 563M Sales 2021 9.8M 10.59M 885M Capitalization 33.89M 36.62M 3.06B
Net income 2020 -13M -14.05M -1.17B Net income 2021 -9M -9.72M -813M EV / Sales 2020 6.74 x
Net cash position 2020 3.15M 3.4M 284M Net cash position 2021 293K 317K 26.45M EV / Sales 2021 3.43 x
P/E ratio 2020
-2.91 x
P/E ratio 2021
-3.8 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 38.31%
More Fundamentals * Assessed data
Dynamic Chart
1 week-27.59%
Current month-27.59%
1 month-43.24%
3 months-16.67%
6 months-13.93%
Current year-4.55%
More quotes
1 week
0.01
Extreme 0.009
0.02
1 month
0.01
Extreme 0.009
0.03
3 years
0.01
Extreme 0.008
3.02
5 years
0.01
Extreme 0.008
7.84
10 years
0.01
Extreme 0.008
23.79
More quotes
Managers TitleAgeSince
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman - 29/05/29
Director/Board Member - 07/10/07
More insiders
Date Price Change
12/24/12 0.0105 -30.00%
11/24/11 0.015 +42.86%
10/24/10 0.0105 -27.59%
07/24/07 0.0145 0.00%
06/24/06 0.0145 0.00%

Delayed Quote Börse Stuttgart, June 13, 2024 at 01:15 am IST

More quotes
Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.
More about the company

Annual profits - Rate of surprise